International Clinical Trial: LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459959) titled 'LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Johns Hopkins University

Condition: Alzheimer s Disease

Intervention: Drug: Lithium orotate

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: June 1, 2026

Target Sample Size: 40

To know more, visit https://clinicaltrials.gov/...